Citius Oncology (CTOR) Cash from Investing Activities (2023 - 2026)
Citius Oncology's (CTOR) quarterly Cash from Investing Activities came in at -$600000.0 in Q1 2026, up 86.36% on a QoQ basis from -$4.4 million in Q4 2025.
Citius Oncology (CTOR) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has 4 years of Cash from Investing Activities data on file, last reported at -$600000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$600000.0 in Q1 2026; TTM through Mar 2026 was $19.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$5.8 million, down 15.0% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$600000.0, up from -$4.4 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for CTOR reached as high as $24.7 million in Q1 2024 and fell as low as -$4.4 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged $3.8 million across 4 years, with a median of -$600000.0 in 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Citius Oncology | 57.02 Mn | 57.02 Mn | 1.34 Mn | -600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600,000.00 |
| Mar 31, 2026 | -600,000.00 |
| Dec 31, 2025 | -4.40 Mn |
| Dec 31, 2025 | -4.40 Mn |
| Jun 30, 2024 | 68,644.00 |
| Jun 30, 2024 | 68,644.00 |
| Mar 31, 2024 | 24.74 Mn |
| Mar 31, 2024 | 24.74 Mn |
| Sep 30, 2023 | -660,000.00 |
| Sep 30, 2023 | -660,000.00 |